Previous studies have shown that NLRP3 inhibition (68) reduces MDSC infiltration into the tumor suggesting an additional mechanism for how CX3CR1 mAb blockade can reduce tumor immune evasion. This evidence concerns the gene CX3CR1 and neoplasm.